CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,877,105 | -28.9% | 1,183,880 | -21.2% | 0.01% | -30.8% |
| Q2 2023 | $49,036,211 | -5.7% | 1,503,256 | +1.7% | 0.01% | -13.3% |
| Q1 2023 | $51,992,557 | -21.8% | 1,477,481 | +1.8% | 0.02% | -21.1% |
| Q4 2022 | $66,473,502 | -2.7% | 1,450,753 | +2.9% | 0.02% | -13.6% |
| Q3 2022 | $68,339,000 | +217.6% | 1,410,489 | +157.6% | 0.02% | +214.3% |
| Q2 2022 | $21,515,000 | +46.6% | 547,599 | +37.4% | 0.01% | +75.0% |
| Q1 2022 | $14,674,000 | -57.6% | 398,649 | -47.5% | 0.00% | -50.0% |
| Q4 2021 | $34,625,000 | +126.9% | 759,669 | +77.9% | 0.01% | +100.0% |
| Q3 2021 | $15,263,000 | +82.9% | 427,059 | +1.2% | 0.00% | +100.0% |
| Q2 2021 | $8,347,000 | -14.7% | 421,796 | +0.3% | 0.00% | -33.3% |
| Q1 2021 | $9,781,000 | +6.2% | 420,512 | -5.1% | 0.00% | 0.0% |
| Q4 2020 | $9,206,000 | -1.3% | 443,028 | +2.9% | 0.00% | 0.0% |
| Q3 2020 | $9,325,000 | -32.9% | 430,709 | -26.9% | 0.00% | -40.0% |
| Q2 2020 | $13,896,000 | +249.8% | 589,567 | +74.9% | 0.01% | +150.0% |
| Q1 2020 | $3,973,000 | +7.1% | 337,035 | -3.6% | 0.00% | +100.0% |
| Q4 2019 | $3,709,000 | -19.9% | 349,568 | -14.0% | 0.00% | 0.0% |
| Q3 2019 | $4,628,000 | +17.4% | 406,706 | +16.1% | 0.00% | 0.0% |
| Q2 2019 | $3,942,000 | +3.1% | 350,444 | -25.9% | 0.00% | 0.0% |
| Q1 2019 | $3,825,000 | +9.3% | 472,840 | -14.6% | 0.00% | 0.0% |
| Q4 2018 | $3,500,000 | -52.7% | 553,762 | -26.2% | 0.00% | -50.0% |
| Q3 2018 | $7,396,000 | +124.5% | 750,829 | +89.2% | 0.00% | +100.0% |
| Q2 2018 | $3,294,000 | +115.2% | 396,915 | +86.6% | 0.00% | 0.0% |
| Q1 2018 | $1,531,000 | +37.4% | 212,673 | +55.6% | 0.00% | – |
| Q4 2017 | $1,114,000 | -90.4% | 136,693 | -83.0% | 0.00% | -100.0% |
| Q3 2017 | $11,641,000 | +14.4% | 802,850 | -4.6% | 0.00% | +33.3% |
| Q2 2017 | $10,177,000 | +692.6% | 841,147 | +742.0% | 0.00% | – |
| Q1 2017 | $1,284,000 | +633.7% | 99,897 | +592.0% | 0.00% | – |
| Q4 2016 | $175,000 | -80.9% | 14,436 | -85.6% | 0.00% | – |
| Q3 2016 | $918,000 | +600.8% | 99,989 | +624.9% | 0.00% | – |
| Q2 2016 | $131,000 | -92.2% | 13,794 | -94.2% | 0.00% | -100.0% |
| Q1 2016 | $1,680,000 | -57.7% | 238,325 | -37.2% | 0.00% | -50.0% |
| Q4 2015 | $3,969,000 | +57.7% | 379,459 | +0.9% | 0.00% | +100.0% |
| Q3 2015 | $2,517,000 | +2606.5% | 376,223 | +2593.5% | 0.00% | – |
| Q2 2015 | $93,000 | +12.0% | 13,968 | +27.0% | 0.00% | – |
| Q3 2013 | $83,000 | – | 10,998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |